| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Legend Biotech Corporation's insiders have reduced their positions by a net 32,800 shares worth roughly $309K.
Counted by filing, the last 12 months brought no open-market purchases and 5 sales by 4 insiders worth about $567K. There were none in the 12 months before that either.
None of the 5 sales in the last 12 months was marked as made under a Rule 10b5-1 trading plan.
No open-market purchase by an insider appears in the LEGN Form 4 filings on record.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.13M | $24.31M | - | |
| CEO | 238.5K | $5.12M | - | |
| Dir | 92.1K | $1.98M | - | |
| Dir | 69.6K | $1.49M | - | |
| Dir | 65.3K | $1.40M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Corazon (Corsee) D. Sanders69 | Director | Sell | 27,370 | $9.46 | $258,920.20 | -34.2% | - | - | |
| Sep 21, 2026 | Carlos E Santos | Chief Financial Officer | Sell | 5,430 | $9.14 | $49,630.20 | -27.6% | - | - | |
| Jun 30, 2026 | Patrick John Casey | Director | Sell | 6,000 | $14.80 | $88,800.00 | -11.0% | -35.5% | - | |
| Jun 25, 2026 | Ying Huang | Chief Executive Officer | Sell | 5,566 | $14.78 | $82,265.48 | -2.2% | -35.1% | - | |
| Mar 25, 2026 | Ying Huang | Chief Executive Officer | Sell | 9,936 | $8.77 | $87,138.72 | -3.9% | +66.5% | - |